🔎 Trials Near Me

Početna › Dijabetes tipa 1 › Washington › Seattle

Kliničke studije za Dijabetes tipa 1 u gradu Seattle, WA

18 studija za Dijabetes tipa 1 traži sudionike na lokacijama u gradu Seattle i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Type 1 Diabetes Extension Study

U tijeku regrutacijaOpažajna studija
  • Benaroya Research Institute, Seattle
Od 8 do 35 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT02734277

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

U tijeku regrutacijaFaza 2
  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Od 18 do 69 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07699380

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

U tijeku regrutacijaFaza 3
  • Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
Od 1 do 25 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

U tijeku regrutacijaFaza 1/2
  • Benaroya Research Institute, Seattle
  • University of Washington Diabetes Institute, Seattle
Od 12 do 35 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

U tijeku regrutacijaFaza 2
  • Benaroya Research Institute, Seattle
Od 4 do 34 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

U tijeku regrutacijaFaza 2
  • Benaroya Research Institute, Seattle
Od 8 do 45 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

U tijeku regrutacijaFaza 1/2
  • Seattle Children's Hospital, Seattle
Od 9 do 20 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07061574

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

U tijeku regrutacijaFaza 2
  • Benaroya Research Institute at Virginia Mason, Seattle
Od 5 do 40 godina · Oba spola · Ažurirano 24. kol 2026. · NCT07187531

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

U tijeku regrutacija
  • University of Washington, Seattle
Od 18 do 65 godina · Oba spola · Ažurirano 16. srp 2026. · NCT06880835

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

U tijeku regrutacijaFaza 2
  • University of Washington, Seattle
Od 18 godina i više · Oba spola · Ažurirano 2. lip 2026. · NCT05822609

Kidney Precision Medicine Project

U tijeku regrutacijaOpažajna studija
  • University of Washington, Seattle
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT04334707

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

U tijeku regrutacijaFaza 3
  • University of Washington, Seattle
Od 18 do 75 godina · Oba spola · Ažurirano 24. ožu 2026. · NCT06217302

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

U tijeku regrutacijaFaza 3
  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Od 18 do 49 godina · Oba spola · Ažurirano 4. ožu 2026. · NCT05819138

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

U tijeku regrutacijaOpažajna studija
  • Benaroya Research Institute, Seattle
Do 70 godina · Oba spola · Ažurirano 19. pro 2025. · NCT03369821

InvesT1D: Promoting Adolescent Investment in Diabetes Care

U tijeku regrutacija
  • Seattle Children's, Seattle
Od 12 godina i više · Oba spola · Ažurirano 16. pro 2025. · NCT06384911

TrialNet Pathway to Prevention of T1D

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Benaroya Research Institute, Seattle
Od 2 do 45 godina · Oba spola · Ažurirano 1. srp 2025. · NCT00097292

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

U tijeku regrutacijaFaza 1
  • Seattle Children's Hospital, Seattle
Od 12 do 25 godina · Oba spola · Ažurirano 13. lip 2025. · NCT05065372

Studije za Dijabetes tipa 1 u drugim gradovima

Ostale studije u gradu Seattle

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.